Regenerative Medicine Industry in Asia Pacific to Show Highest Growth Rate between 2013 and 2019

Regenerative Medicine Industry in Asia Pacific to Show Highest Growth Rate between 2013 and 2019

  • Submitted By: Alinajohn
  • Date Submitted: 04/14/2015 2:50 AM
  • Category: Business
  • Words: 901
  • Page: 4
  • Views: 1

Regenerative Medicine Industry in Asia Pacific to Show Highest Growth Rate between 2013 and 2019

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019


Regenerative medicines possess the distinctive capability to repair, reinstate, and regenerate tissues and organs damaged owing to injuries, diseases, or because of natural progression of age. These regenerative medicines are capable of re-establishing the functionality of tissues and organs. These medicines are applicable in a broad range of degenerative disorders such as dermatology, cardiovascular and neurodegenerative diseases, and orthopedic applications. Medical professionals and scientists are researching to develop technologies based on genes, biologics, somatic and stem cells.

Browse Full Global Regenerative Medicine Market Report With Complete TOC @ http://www.transparencymarketresearch.com/regenerative-medicines-market.html


Technological Development to Drive Global Regenerative Medicine Industry

The technological development in tissue engineering and stem cell therapy is likely to augment the growth in the global regenerative medicine market particularly the bone and joint segment. In addition to this, the rising prevalence of bone and joint disorders has also caused the regenerative medicine market to grow at a healthy pace. However, some factors such as strict regulatory measures, ethical issues related to stem cell therapy, and infections occurring post implant are likely to hamper the development in the global market for regenerative medicine during the period of 2013 to 2019.

Biomaterial, stem cell therapy, and tissue engineering are the three segments of the global regenerative medicine industry according to the...

Similar Essays